Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Dow
Baxter
Fuji
Express Scripts
Mallinckrodt
US Army
Argus Health
Teva

Generated: May 20, 2018

DrugPatentWatch Database Preview

PROSOM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Prosom, and when can generic versions of Prosom launch?

Prosom is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in PROSOM is estazolam. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estazolam profile page.
Summary for PROSOM
Drug patent expirations by year for PROSOM
Medical Subject Heading (MeSH) Categories for PROSOM
Synonyms for PROSOM
12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0;{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene
12-CHLORO-9-PHENYL-2,4,5,8-TETRAAZATRICYCLO[8.4.0.0(2),?]TETRADECA-1(10),3,5,8,11,13-HEXAENE
29975-16-4
36S3EQV54C
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-
4H-[1,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-
4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-
4H-s-Triazolo[4,4]benzodiazepine, 8-chloro-6-phenyl-
53180-72-6
8-chloranyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-6-phenyl-4H-(1,2,4)triazolo-(4,3-a)(1,4)benzodiazepine
8-Chloro-6-phenyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-6-phenyl-4H-[1,4]triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-6-phenyl-4H-2,3,5,10b-tetraaza-benzo[e]azulene
8-CHLORO-6-PHENYL-4H-BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE
8-chloro-6-phenyl-4H-s-triazolo [4,3-a][1,4] benzodiazepine
8-chloro-6-phenyl-4H-s-triazolo-[4,3-a][1,4]benzodiazepine
8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine (IUPAC)
8-chloro-6-phenyl-4H-s-triazolo[4,3-(alpha)] [1,4]benzodiazepine
8-Chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-6-phenyl-4H-s-triazolo[4,4]benzodiazepine
975E164
A820132
AB07556
Abbott 47631
Abbott Brand of Estazolam
Abbott-47631
AC1L1FJ8
AK396544
AKOS005064373
AN-6775
BIDD:GT0481
BRN 1220868
C-18475
C06981
C16H11ClN4
Cannoc
CAS-29975-16-4
CC-27529
CCRIS 1955
CDCHDCWJMGXXRH-UHFFFAOYSA-
CDCHDCWJMGXXRH-UHFFFAOYSA-N
CHEBI:4858
CHEMBL285674
D 40TA
D-40TA
D00311
D0P2CK
D40TA
DB01215
DEA No. 2756
DSSTox_CID_572
DSSTox_GSID_20572
DSSTox_RID_75665
DTXSID5020572
EINECS 249-982-4
Esilgan
estazolam
Estazolam (JP15/USAN/INN)
Estazolam (JP17/USAN/INN)
Estazolam [USAN:INN:JAN]
Estazolam 0.1 mg/ml in Methanol
Estazolam 1.0 mg/ml in Methanol
estazolam 100 ug per ml in methanol
Estazolam solution, drug standard, 100 mug/L in methanol
Estazolam, United States Pharmacopeia (USP) Reference Standard
Estazolamum
Estazolamum [INN-Latin]
Eurodin
Eurodin (TN)
Eurodin|||ProSom
FT-0630552
GTPL7550
HormonaBrand of Estazolam
I06-0352
InChI=1/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2
Julodin
LS-7378
MFCD00867537
MLS003899222
NCGC00168250-01
Nemurel
NSC 290818
NSC-290818
NSC290818
Nuctalon
PL005308
Prosom (TN)
Q-201071
SCHEMBL28766
SMR000238168
Somnatrol
Takeda Brand of Estazolam
Tasedan
Tox21_112609
U 33737
UNII-36S3EQV54C
WLN: T B576 BN DNN HN GHJ IR& LG
ZINC1370

US Patents and Regulatory Information for PROSOM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott PROSOM estazolam TABLET;ORAL 019080-001 Dec 26, 1990 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbott PROSOM estazolam TABLET;ORAL 019080-002 Dec 26, 1990 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Chubb
McKinsey
Federal Trade Commission
Baxter
Mallinckrodt
US Department of Justice
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.